Business

Presents at Dementia Challenge seminar in Beijing

Presents at Dementia Challenge seminar in Beijing.

articleIxico PlcJanuary 13, 20143/company/ixico-plc/news/presents-at-dementia-challenge-seminar-in-beijing
Presents at Dementia Challenge seminar in Beijing

About this update from Ixico Plc

[{"type":"text","content":"\n \nRNS Number : 4846X IXICO plc 13 January 2014  \n \n\n \nIXICO announces that CEO Derek Hill today presented at a seminar on the Dementia Challenge being held in Beijing, China\n \n13 January 2014 - IXCO plc (\"IXICO\" or the \"Company\"), the brain health company, announces that Derek Hill, IXICO's CEO, today presented at 'Facing the Dementia Challenge: UK and China perspectives on diagnosis, treatment and care,' a seminar sponsored by the British Government and held in Beijing, China.  The seminar is being attended by UK Cabinet Minister Ken Clarke (the Prime Minister's Trade Envoy focusing on health) and Li Bin, China's Minister of the National Health and Family Planning Commission who both gave opening remarks.  Professor Hill gave a presentation entitled 'Dementia diagnosis - the UK perspective.'\n \nEnquiries\nIXICO plc\n+44 207 691 2064\nDerek Hill, CEO\nCharles Spicer, VP Corporate Development\n \nPeel Hunt LLP (Nominated Adviser and broker)\n+44 207 418 8900\nJames Steel\n \nFTI Consulting Limited (U.K. Investor Relations)\n+44 207 831 3113\nJohn Dineen\nSimon Conway\n \nAbout IXICO\nIXICO, the brain health company, was founded in 2004 with a mission to translate image acquisition, management and analysis technology and know-how, which the founders had developed together, into commercial products targeting the expanding area of imaging to inform decision-making during drug development. This has resulted in commercially successful products being launched in the clinical trials (Phase 0-III) and experimental medicine markets and being readied for launch into the wider clinical diagnostic market. Since incorporation, IXICO has been contracted by eight of the top 15 global pharmaceutical companies as well as leading biotechnology companies. In October 2013, IXICO plc was admitted to trading on AIM. More information is available on www.ixico.com\n \n\nThis information is provided by RNSThe company news service from the London Stock Exchange  END  NRAGGUUAGUPCUBW\n ","length":2713,"tagName":"div"}]

More updates from Ixico Plc